Metoprolol Comp. Abz

Metoprolol Tartrate/Hydrochlorothiazide, the active ingredient in Metoprolol Comp. Abz, is a beta‑blocker and thiazide diuretic presented as a tablet for oral use. It is used to lower blood pressure and manage heart failure in adult patients.

GNH USA supplies Metoprolol Comp. Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Comp. Abz combines a beta‑blocker and a thiazide diuretic to treat cardiovascular conditions that involve elevated blood pressure or cardiac workload.

Hypertension: reduction of systolic and diastolic blood pressure. Heart failure: improvement of symptoms and reduction of hospitalization risk. Angina pectoris: relief of chest pain by decreasing myocardial oxygen demand.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Fatigue or weakness - Headache - Cold extremities - Increased urinary frequency - Mild electrolyte disturbances (e.g., low potassium)

Serious or Rare Side Effects: - Severe hypotension - Bradycardia or heart block - Significant electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Acute renal impairment - Allergic reactions such as rash or angioedema

Before initiating therapy, several safety considerations should be addressed.

Monitor blood pressure: ensure adequate control without excessive drop. Monitor heart rate: watch for bradycardia, especially in patients with conduction disorders. Assess renal function: adjust use in impaired kidneys. Review electrolyte levels: particularly potassium and sodium. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Metoprolol Comp. Abz may interact with several drug classes.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia and hypotension. - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Strong CYP2D6 inhibitors (e.g., quinidine, fluoxetine): increased metoprolol plasma levels.

Moderate Interactions (Monitor Closely): - Other antihypertensives (ACE inhibitors, ARBs): enhanced blood pressure lowering. - NSAIDs: may reduce diuretic efficacy and affect renal function. - Antidiabetic agents: potential alteration of glucose control.